Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
4.000
-0.190 (-4.53%)
At close: Jul 19, 2024, 4:00 PM
4.010
+0.010 (0.25%)
Pre-market: Jul 22, 2024, 4:24 AM EDT
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $6.69 million as of July 22, 2024. Its market cap has decreased by -85.36% in one year.
Market Cap
6.69M
Enterprise Value
27.11M
1-Year Change
-85.36%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since the IPO on June 18, 2021, Telesis Bio's market cap has decreased from $451.66M to $6.69M, a decrease of -98.52%. That is a compound annual growth rate of -74.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 6.70M | -44.17% |
| Dec 29, 2023 | 12.00M | -66.10% |
| Dec 30, 2022 | 35.40M | -88.82% |
| Dec 31, 2021 | 316.50M | -29.93% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 6.88M |
| Sunshine Biopharma | 6.88M |
| Alaunos Therapeutics | 6.76M |
| Tenax Therapeutics | 6.70M |
| NuCana | 6.69M |
| Xenetic Biosciences | 6.41M |
| Chromocell Therapeutics | 6.40M |
| ReShape Lifesciences | 6.21M |